Login
Home
Charts
Search
Watchlist
Products

IIFL Capital Services Ltd

IIFLCAPS·NSE
345.05+0.19%Tue, 22 Sept '26 15:53

IIFL Capital Services Ltd

IIFLCAPS
NSE
345.05
+0.19%
|Tue, 22 Sept '26 15:53
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
10,902Cr
Close
Close Price
345.90
Industry
Industry
Finance - Capital Markets - Brokers
PE
Price To Earnings
18.84
PS
Price To Sales
4.48
Revenue
Revenue
2,434Cr
Rev Gr TTM
Revenue Growth TTM
2.17%
PAT Gr TTM
PAT Growth TTM
-18.96%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
507559686640645583537617572586644631
Growth YoY
Revenue Growth YoY%
60.163.470.856.427.34.3-21.8-3.5-11.40.619.92.3
Expenses
ExpensesCr
348318350340379337351396359396421406
Operating Profit
Operating ProfitCr
159240337300266245186221213190224226
OPM
OPM%
31.443.049.146.841.342.134.635.837.232.534.735.8
Other Income
Other IncomeCr
272318458643663-251341090
Interest Expense
Interest ExpenseCr
304354444845434053536360
Depreciation
DepreciationCr
161863121314161615171717
PBT
PBTCr
140203237248264250163228120254155239
Tax
TaxCr
325357655853355235664055
PAT
PATCr
10815118118220519712817685188115184
Growth YoY
PAT Growth YoY%
94.0133.1109.0144.290.831.0-29.1-3.7-58.5-4.8-10.14.9
NPM
NPM%
21.226.926.328.531.833.923.828.414.932.017.929.2
EPS
EPS
3.54.95.95.96.76.44.15.72.76.03.75.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
507559686640645583537617572586644631
Growth YoY
Revenue Growth YoY%
60.163.470.856.427.34.3-21.8-3.5-11.40.619.92.3
Expenses
ExpensesCr
348318350340379337351396359396421406
Operating Profit
Operating ProfitCr
159240337300266245186221213190224226
OPM
OPM%
31.443.049.146.841.342.134.635.837.232.534.735.8
Other Income
Other IncomeCr
272318458643663-251341090
Interest Expense
Interest ExpenseCr
304354444845434053536360
Depreciation
DepreciationCr
161863121314161615171717
PBT
PBTCr
140203237248264250163228120254155239
Tax
TaxCr
325357655853355235664055
PAT
PATCr
10815118118220519712817685188115184
Growth YoY
PAT Growth YoY%
94.0133.1109.0144.290.831.0-29.1-3.7-58.5-4.8-10.14.9
NPM
NPM%
21.226.926.328.531.833.923.828.414.932.017.929.2
EPS
EPS
3.54.95.95.96.76.44.15.72.76.03.75.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8358357247911,2321,3522,1612,4052,4202,434
Growth
Revenue Growth%
0.1-13.39.355.89.759.911.30.62.2
Expenses
ExpensesCr
4874584334887498871,2871,4081,5721,581
Operating Profit
Operating ProfitCr
348378291303483465874997848853
OPM
OPM%
41.745.240.238.439.234.440.541.535.035.0
Other Income
Other IncomeCr
112406677841870162183210
Interest Expense
Interest ExpenseCr
1451151025010276148180210229
Depreciation
DepreciationCr
374255466367114556565
PBT
PBTCr
274258301285402341683925756768
Tax
TaxCr
938768649691169212193196
PAT
PATCr
181171234220306250513713564572
Growth
PAT Growth%
-5.136.5-5.838.8-18.3105.538.9-20.9-19.0
NPM
NPM%
21.620.532.327.924.818.523.829.623.323.5
EPS
EPS
5.75.47.37.010.18.216.723.118.118.4
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8358357247911,2321,3522,1612,4052,4202,434
Growth
Revenue Growth%
0.1-13.39.355.89.759.911.30.62.2
Expenses
ExpensesCr
4874584334887498871,2871,4081,5721,581
Operating Profit
Operating ProfitCr
348378291303483465874997848853
OPM
OPM%
41.745.240.238.439.234.440.541.535.035.0
Other Income
Other IncomeCr
112406677841870162183210
Interest Expense
Interest ExpenseCr
1451151025010276148180210229
Depreciation
DepreciationCr
374255466367114556565
PBT
PBTCr
274258301285402341683925756768
Tax
TaxCr
938768649691169212193196
PAT
PATCr
181171234220306250513713564572
Growth
PAT Growth%
-5.136.5-5.838.8-18.3105.538.9-20.9-19.0
NPM
NPM%
21.620.532.327.924.818.523.829.623.323.5
EPS
EPS
5.75.47.37.010.18.216.723.118.118.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0064616161626262
Reserves
ReservesCr
5606678169071,1211,2891,7252,4453,003
Current Liabilities
Current LiabilitiesCr
2,1542,1321,1712,3744,5893,7105,7244,8875,837
Non Current Liabilities
Non Current LiabilitiesCr
84187383203271178363559649
Total Liabilities
Total LiabilitiesCr
2,8623,0502,4343,5446,0415,2377,8757,9569,558
Current Assets
Current AssetsCr
1,9761,9521,6262,8164,8324,1866,3846,1277,404
Non Current Assets
Non Current AssetsCr
8861,0978087281,2091,0511,4911,8292,154
Total Assets
Total AssetsCr
2,8623,0502,4343,5446,0415,2377,8757,9569,558
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0064616161626262
Reserves
ReservesCr
5606678169071,1211,2891,7252,4453,003
Current Liabilities
Current LiabilitiesCr
2,1542,1321,1712,3744,5893,7105,7244,8875,837
Non Current Liabilities
Non Current LiabilitiesCr
84187383203271178363559649
Total Liabilities
Total LiabilitiesCr
2,8623,0502,4343,5446,0415,2377,8757,9569,558
Current Assets
Current AssetsCr
1,9761,9521,6262,8164,8324,1866,3846,1277,404
Non Current Assets
Non Current AssetsCr
8861,0978087281,2091,0511,4911,8292,154
Total Assets
Total AssetsCr
2,8623,0502,4343,5446,0415,2377,8757,9569,558

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-110587352152795-793-118871-1,070
Investing Cash Flow
Investing Cash FlowCr
-129016148-86163-74-177314
Financing Cash Flow
Financing Cash FlowCr
463-494-514-361108-296430-490568
Net Cash Flow
Net Cash FlowCr
22393-146-62817-925239204-187
Free Cash Flow
Free Cash FlowCr
-20852742389822-798-138922-936
CFO To PAT
CFO To PAT%
-61.2342.3150.368.9259.9-317.4-22.9122.2-189.8
CFO To EBITDA
CFO To EBITDA%
-31.8155.4120.850.1164.6-170.6-13.487.3-126.1
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-110587352152795-793-118871-1,070
Investing Cash Flow
Investing Cash FlowCr
-129016148-86163-74-177314
Financing Cash Flow
Financing Cash FlowCr
463-494-514-361108-296430-490568
Net Cash Flow
Net Cash FlowCr
22393-146-62817-925239204-187
Free Cash Flow
Free Cash FlowCr
-20852742389822-798-138922-936
CFO To PAT
CFO To PAT%
-61.2342.3150.368.9259.9-317.4-22.9122.2-189.8
CFO To EBITDA
CFO To EBITDA%
-31.8155.4120.850.1164.6-170.6-13.487.3-126.1

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9921,4182,6941,5283,7766,7427,59610,902
Price To Earnings
Price To Earnings
4.26.48.86.17.49.513.518.8
Price To Sales
Price To Sales
1.31.72.11.11.72.73.04.5
Price To Book
Price To Book
1.11.52.31.12.12.72.53.6
EV To EBITDA
EV To EBITDA
1.50.1-0.9-1.80.53.75.18.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
OPM
OPM%
41.745.240.238.439.234.440.541.535.035.0
NPM
NPM%
21.620.532.327.924.818.523.829.623.323.5
ROCE
ROCE%
25.226.130.126.628.122.728.332.119.819.8
ROE
ROE%
32.325.726.622.825.918.528.728.418.418.4
ROA
ROA%
6.35.69.66.25.14.86.59.05.95.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9921,4182,6941,5283,7766,7427,59610,902
Price To Earnings
Price To Earnings
4.26.48.86.17.49.513.518.8
Price To Sales
Price To Sales
1.31.72.11.11.72.73.04.5
Price To Book
Price To Book
1.11.52.31.12.12.72.53.6
EV To EBITDA
EV To EBITDA
1.50.1-0.9-1.80.53.75.18.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
OPM
OPM%
41.745.240.238.439.234.440.541.535.035.0
NPM
NPM%
21.620.532.327.924.818.523.829.623.323.5
ROCE
ROCE%
25.226.130.126.628.122.728.332.119.819.8
ROE
ROE%
32.325.726.622.825.918.528.728.418.418.4
ROA
ROA%
6.35.69.66.25.14.86.59.05.95.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
- **IIFL Capital Services is fundamentally a research house that learned to trade - it began in 1995 as an equity research firm founded by first-generation entrepreneurs, built a retail brokerage on top of that insight, and then spent three decades layering on institutional execution, investment banking, and wealth management, all anchored to the same idea: if you understand companies deeply, you can serve every constituency that touches them. The company was demerged from its former parent over 2019-2022 into a standalone listed entity, and in 2024 it renamed itself from IIFL Securities to IIFL Capital Services, signalling a deliberate pivot from earning commissions on transactions to gathering assets and managing wealth for the long term. The recurring approach that explains the whole structure is a three-pillar philosophy - research, technology, and talent - applied across every business line, so that the same analyst coverage that wins a sovereign wealth fund’s trading mandate also populates the model portfolio of a domestic family office.** # Business segments Three engines built on a single research core - a broking and wealth franchise that gathers assets from over three million Indians, an institutional platform that converts research into execution for a thousand global funds, and an investment bank that uses both distribution networks to lead India’s IPO league tables. ## 1. Broking and wealth management: where trading relationships become long-term assets **A phygital network of branches, partners and a highly rated app brings retail and affluent clients onto the platform, where relationship managers then convert active traders into fee-generating wealth mandates.** - **Research is the front door** - the company was founded on equity research, and every broking client receives research-backed advisory rather than bare execution, which is why the mobile app ‘IIFL Markets’ carries a 4.3 rating and has been downloaded over 12.3 million times. - **Phygital reach, not just digital** - 100-plus branches and 2,600-plus external partners across 2,000 towns feed a pipeline that digital-only platforms cannot replicate, with roughly 50,000 new customers added in a single quarter. - **Segmented by net worth, not just activity** - clients with financial assets above ₹10 million are served by a Private Client Group, those in the ₹1-10 million band by franchisees, creating a natural escalator into wealth management as clients grow richer. - **Trading funds the wealth pivot** - the margin trading book stood at ₹14.5 billion, and equity assets held in demat accounts reached ₹1,775 billion, giving the firm a captive pool of assets to cross-sell into mutual funds, PMS, AIFs and insurance. - **Closed-loop cross-sell** - active traders are systematically converted into wealth clients through a model that layers on lending, structured solutions and family-office services, so that distribution AUM reached ₹521 billion, with mutual funds alone accounting for ₹211.7 billion. ## 2. Institutional equities: a research engine that global funds pay to access **A team of 48 analysts covering 318 stocks - more than 72% of India’s market capitalisation - feeds ideas to approximately 1,100 institutional clients through sales desks in Mumbai, Singapore, London and New York.** - **Coverage breadth is the moat** - the research team has grown steadily from 30 analysts covering 225 stocks to 48 analysts covering 318 stocks, spanning 20-plus sectors, which makes the firm a “port of call for most investors” entering India. - **Execution, not just ideas** - the platform offers Direct Market Access, algorithmic trading, high-touch block trading and a dedicated derivatives desk, upgraded with a next-generation Order Management System and servers colocated at the exchange for ultra-low latency. - **Global distribution, local depth** - clients include sovereign wealth funds, pension funds, mutual funds, insurers and hedge funds across 60 countries, and the firm holds its flagship “Enterprising India” conference in Mumbai with over 165 corporates and 800-plus investors. - **An alternatives desk that others lack** - a differentiated team offers ideas around special situations, index inclusions and exclusions, rebalancing and momentum themes, which broadens the revenue opportunity beyond plain-vanilla cash equities. ## 3. Investment banking: the banker of choice for India’s entrepreneurial mid-cap **A top-ranked IPO franchise that can fill all three buckets of a public offering - retail, HNI and institutional - using the group’s own distribution pipes, without depending on outside syndicates.** - **Number one by deal count** - the firm held a 25.9% market share of mainboard IPOs in FY2026 and completed 45 transactions across capital markets and advisory that year, including five IPOs and three private-placement deals in the final quarter alone. - **Own distribution is the differentiator** - because the group already serves over three million retail customers, a large HNI base and 1,100 institutions, it can place IPO paper across every investor category without relying on third-party distributors, which is rare among Indian investment banks. - **Mid-cap roots, moving up** - the franchise is firmly entrenched in mid-cap IPOs and has been expanding into larger transactions, while also diversifying into debt deals and M&A advisory to reduce dependence on equity capital markets cycles. - **Repeat business proves the model** - the strategy is explicitly built around being the “Banker of choice” for entrepreneurs, with repeat mandates forming a hallmark of the franchise, and the firm has won industry awards including “India Equity House” from IFR Asia. # Research **The firm’s single shared capability - a 48-person team covering 318 stocks - powers every business line, from the institutional trading desk in New York to the wealth manager advising a family office in Delhi.** - **Coverage that mirrors the market** - the 318 stocks span large-caps (79 above US$10 billion), mid-caps and small-caps, together representing over 72% of India’s total market capitalisation, so the research is relevant to global funds and domestic retail alike. - **Ideas flow both ways** - institutional equities converts research into execution and liquidity, while private wealth translates the same ideas into client portfolios and asset-allocation strategies, creating a single cost base that serves two revenue streams. - **Built, not bought** - the company was founded as Probity Research in 1995, and research has been the foundation ever since; the team has grown steadily over three decades rather than being assembled through acquisitions. # Group structure and partners **A listed entity with a long-standing strategic shareholder in Fairfax Financial, a growing asset-management subsidiary, and a network of insurance and facilities arms that support the core capital-markets franchise.** - **Fairfax is gaining control** - Fairfax Group entities (the Acquirer and PAC together) held 24.67% as of the PA date and launched a mandatory open offer to acquire up to 26% more, with a parallel preferential issue and promoter share sale designed to take total holding to 51%, giving Fairfax the right to nominate two non-executive directors. - **Asset management is being consolidated** - the wholly owned subsidiary IIFL Capital Asset Management Limited (formerly IIFL Securities Alternate Asset Management Limited) was renamed in 2025 to serve as investment manager to AIFs and PMS, and the group is transferring both the AIF and PMS businesses into it via slump sales, creating a dedicated asset-manufacturing entity. - **Insurance and wellness sit in separate subsidiaries** - Livlong Insurance Brokers Limited holds a direct broker licence from IRDAI, while Livlong Protection and Wellness Solutions Limited obtained a composite corporate agent licence in December 2024, enabling it to solicit life, general and health insurance. - **A GIFT City presence is underway** - in May 2026 the company incorporated IIFL Capital (IFSC) Limited in Gujarat’s GIFT City to act as a broker-dealer and distributor under IFSCA regulations, extending the platform into India’s international financial centre. - **Governance and scale** - the board has 50% independent directors with a separate chairperson and managing director, the company holds a CRISIL AA-/Stable long-term rating, and it employs 1,558 people with ISO certifications in information security, business continuity and environmental management.

Documents — IIFL Capital Services Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/as-67cbf8ddfc4d5263965d00b0.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/31f2zeas1hoxvoyq9e50wgz9.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/lyeshw6qspr4whjmcthvvvly.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/43pnfeu1wb8smfyx1loqj4nj.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/mlp18n64x87905l02wvidhe9.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/i81d4152n454iks1ghka0vsh.pdf
  • Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/pc7qnayhvw9ogxkczkapylqb.pdf
  • Q4 FY2023 Earnings Call Transcript (Mar 2023, PDF): https://www.stockscans.in/document/3dvu9ssf39jlx49k7jg7m80n.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/vvpaa62exouq2z75wls2wfcx.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/qg7yxmor492uf0yfjhf67eg8.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/h1kkx7y6m7a08wzwo8ncstlx.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ri4w7q01ow00h0ibw8nmv3q2.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/2igfrakfdpb4d38genaxcd5b.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/bijgtf22nozhcbk6nrdo5zyu.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/uum12lno3bv8yju3z1ujaoqr.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/53m0w4a9129heguisv3ilrc8.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/1ej2a58erwv4uu8g1pnwjuu0.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/xflpuv2md6g752h7rrbf8r55.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/x7e6o4eq2l8ssmcutpdmzkvi.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/in2b7ovctg1co9d2rddrq8dr.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/nfqs9ec7qm20qwqholywzojy.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/7448qzkb7jpv0e7n884qy1ju.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/ba23yjx8x0ai0gpxtubu5wyx.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/p9afpt2242endm1eowd8zqvs.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/3xowwp73gzo9zccbr4g7x846.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ivip5wed0fauj1bnefuwodx8.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/jbadkm0tsdik6adg4ek67wdp.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/ci4hm6m1kwtrpeqbzksevdmg.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/bp3vxgtwwzpa4oecf5bytsgv.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/coervfy72uaev9snbp0t1le0.pdf

Concall Transcript Summaries — IIFL Capital Services Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AIIFLCAPS/transcript-notes/202606/as-67cbf8ddfc4d5263965d00b0.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AIIFLCAPS/transcript-notes/202603/31f2zeas1hoxvoyq9e50wgz9.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AIIFLCAPS/transcript-notes/202512/lyeshw6qspr4whjmcthvvvly.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AIIFLCAPS/transcript-notes/202509/43pnfeu1wb8smfyx1loqj4nj.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AIIFLCAPS/transcript-notes/202506/mlp18n64x87905l02wvidhe9.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AIIFLCAPS/transcript-notes/202503/i81d4152n454iks1ghka0vsh.pdf
  • Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/NSE%3AIIFLCAPS/transcript-notes/202309/pc7qnayhvw9ogxkczkapylqb.pdf
  • Q4 FY2023 Concall Transcript Summary (Mar 2023): https://www.stockscans.in/company/NSE%3AIIFLCAPS/transcript-notes/202303/3dvu9ssf39jlx49k7jg7m80n.pdf